Back to STATE STREET CORP STATE STREET CORP

GANXGANX
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in GAIN THERAPEUTICS INC

STATE STREET CORP holds 157,537 shares of GANX (GAIN THERAPEUTICS INC), worth $319,800 as of 2026-Q2.

Current Value

$319,800

Current Shares

157,537

Total Value Change

+$258,502

Total Shares Change

+123,100

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
157,537
0.0%
$319,8000.0%$2.03
0
2026-Q1
Unchanged
157,537
0.0%
$305,6220.0%$2.63
0
2025-Q4
Increased
157,537
+72.9%
$507,2690.0%$3.05
25
2025-Q3
Increased
91,137
+28.1%
$161,3120.0%$1.81
19
2025-Q2
Unchanged
71,137
0.0%
$128,0470.0%$1.97
0
2025-Q1
Unchanged
71,137
0.0%
$135,8720.0%$1.89
0
2024-Q4
Increased
71,137
+106.6%
$153,6560.0%$2.18
25
2024-Q3
Unchanged
34,437
0.0%
$61,2980.0%$1.99
0

Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used